down arrow

Enliven Therapeutics, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US29337E1029
  • NASDAQ: IMRA
USD
48.19
-0.68 (-1.39%)

Sep 22

NAS

 View all stocks in this country
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryEnliven Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
calendar-icon
calendar-icon
1D
-1.39%
-0.75%
1W
-9.69%
2.04%
1M
-19.44%
0.41%
YTD
212.92%
12.57%
1Y
141.92%
15.76%
3Y
265.91%
78.38%
5Y
1039.24%
73.21%
10Y
%
255.99%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.85%
0%
4.85%
6 Months
66.0%
0%
66.0%
1 Year
141.92%
0%
141.92%
2 Years
107.81%
0%
107.81%
3 Years
265.91%
0%
265.91%
4 Years
1977.16%
0%
1977.16%
5 Years
1039.24%
0%
1039.24%

Enliven Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Footer loading